Cacotheline

• CAT Number: I023945
• CAS Number: 561-20-6
• Molecular Formula: C21H21N3O7
• Molecular Weight: 427.41
• Purity: 98%
• Synonyms: Cacotheline; NSC5069; NSC-5069; NSC 5069
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 2-[(4S,12S,13R,14S,19R,21S)-9-nitro-7,8-dioxo-15-oxa-1,11-diazahexacyclo[16.3.1.04,12.04,21.05,10.013,19]docosa-5,9,17-trien-14-yl]acetic acid
• InChI: InChI=1S/C21H21N3O7/c25-12-6-11-17(18(19(12)28)24(29)30)22-20-16-10-5-14-21(11,20)2-3-23(14)8-9(10)1-4-31-13(16)7-15(26)27/h1,6,10,13-14,16,20,22H,2-5,7-8H2,(H,26,27)/t10-,13-,14-,16-,20-,21+/m0/s1
• InChIKey: IVEMPCACOMNRGI-OFDJEBHLSA-N
• SMILES: C1CN2CC3=CCO[C@H]([C@@H]4[C@H]3C[C@H]2[C@@]15[C@H]4NC6=C(C(=O)C(=O)C=C56)[N+](=O)[O-])CC(=O)O

Cacotheline（Cat No.:I023945）is a synthetic chemical compound primarily studied for its potential use in medicinal and biochemical research. It is known for its neuroprotective and antioxidant properties, which may help mitigate oxidative stress and cellular damage associated with neurological diseases. Cacotheline has been investigated for its role in promoting neuronal survival and reducing inflammation, making it a potential candidate for treatments related to neurodegenerative conditions like Alzheimer’s and Parkinson’s diseases. However, further research is needed to understand its full biological effects, therapeutic potential, and safety profile in clinical settings.